Clostridium difficile postantibiotic diarrhoea diagnosis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 22, Issue 10, 2012, Pages 640-643

  Naqvi, Syed Ali Haider ^a   Chaudhry, Faisal Fiaz ^b  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b Dow International Medical College   (Pakistan)

Author keywords

Amoxicillin; Clostridium difficile; Cycloserine cefoxitin fructose agar (CCFA); Postantibiotic diarrhoea

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFOXITIN; CLAVULANIC ACID; CYCLOSERINE; FRUCTOSE;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; ENTERITIS; FECES CULTURE; FEMALE; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; LIQUID FECES; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; POSTANTIBIOTIC EFFECT; PRESCRIPTION;

ADULT; AGE DISTRIBUTION; AGED; AMOXICILLIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG THERAPY, COMBINATION; FECES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBSERVATION; SECONDARY CARE; SEX DISTRIBUTION;

EID: 84868655879     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Knoop FC, Owens M, Crocker IC. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 1993; 6:251-65.
2. Owens RC, Donskey CJ, Gaynes RP, Loo VJ, Muto CA. Antimicrobial associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46:519-31.
3. Gerding DN, Muto CA, Owens RC. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 45: 543-9.
4. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile: associated diseases in setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45:1543-9.
5. Emerson CR. Clostridium difficile associated diarrhoea: an emerging epidemic: therapeutic options. Pharm Prac 2007; 20:347-53.
6. Suroweic D, Kuyumjian AG, Wynd MA, Cicogna CE. Past, present and future therapies for Clostridium difficile disease. Ann Pharmacother 2006; 40:2155-63.
7. Kelly CP, LaMont JJ. Clostridium difficile: more difficult than ever. N Engl J Med 2008; 359:1932-40.
8. Sonnenberg A. Similar geographical variations of mortality and hospitalization associated with IBD and Clostridium difficile, colitis. Inflam Bowel Dis 2009; 64: 389-93.
9. Sailhamer EA, Carsan K, Chang Y. Fulminant Clostridium difficile colitis, patterns of care and predictors of mortality. Arch Surg 2009; 144:433-9.
10. Yablon SA, Krotenberg R, Fruhmann K. Clostridium difficile related disease, evaluation and prevalence among in-patients with diarrhoea in two free standing rehabilitation hospitals. Arch Phys Med Rehabil 1993; 74:9-13.
11. Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Int Med 1995; 123:83540.
12. Dawson LF, Stabler RA, Wren BW. Assessing the role of p-cresol tolerance in Clostridium difficile. J Med Microbial 2008; 56: 745-9.
13. Sultan Q, Chaudry NA, Muneer M, Anwar MS, Tayyab M. Diagnosis of Clostridium difficile antibiotic associated diarrhoea, culture versus toxin assays. J Pak Med Assoc 2000; 50:246-9.
14. Bloedt K, Riecket M, Poppert S, Wellinghousen N. Evaluation of new selective culture medium and rapid fluorescence in situ hybridization assay for identification of Clostridium difficile from stool samples. J Med Microbiol 2009; 58:874-7.
15. Perry JD, Asir K, Halimi D, Orenga S, Dale J, Payne M, et al. Evaluation of chromogenic culture medium for isolation of Clostridium difficile within 24 hours. J Clin Microbiol 2010, 48: 3852-8.
16. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Sliva J. Clostridium difficile associated diarrhoea and colitis. Shea position paper. Infect Cont Hosp Epid 1995; 168:459-77.
17. McFarland LV. Update on changing epidemiology of Clostridium difficile associated disease. Nat Clin Pract Gastroenterol Hepatol 2008; 5:40-8.
18. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile associated enteric disease. Ann Intern Med 2006; 145: 758-64.
19. Delmee M, Avesani G. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin and tetracycline among 308 isolates of Clostridium difficile. J Antimicrob Chemother 1988; 22:325-31.